| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |